Cantel Medical (CMD) Tops Q4 EPS by 25c

Cantel Medical (NYSE: CMD) reported Q4 EPS of $0.24, $0.25 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $233.4 million versus the consensus estimate of $223.64 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
• SanDisk upgraded at JPMorgan after investor day; shares climb